Stock Financial Ratios, Dividends, Split History

CDEV / Centennial Resource Development, Inc. financial ratios include Market Cap, Enterprise Value, Book Value, Quick Ratio, Current Ratio, NCAV, EBITDA, Profit Margin, Operating Margin, Return on Invested Capital (ROIC), Return on Assets (ROA), Return on Equity (ROE), Piotroski F-Score, Altman Z-Score, Beneish M Score and Kaplan-Zingales KZ-Index.

Valuation Metrics
Price19.78
Volume2,291,100.00
Market Cap ($M)5,150.08
Enterprise Value ($M)5,202.52
Book Value / Share10.89
Price / Book1.87
NCAV ($M)-410.01
NCAV / Share-1.57
Price / NCAV-12.56
Share Statistics
Weighted Average Number Of Shares Outstanding Basic 235,447,000
Common Shares Outstanding2 15,661,338
Weighted Average Number Of Diluted Shares Outstanding 239,754,000
Common Shares Outstanding 260,368,235
Scoring Models
Piotroski F-Score0.00
Altman Z ScoreN/A
Beneish M ScoreN/A
Management Effectiveness (mra)
Return on Invested Capital (ROIC)0.03
Return on Assets (ROA)n/a
Return on Equity (ROE)n/a
Balance Sheet (mrq) ($M)
Assets3,616.57
Liabilities612.60
Quick Ration/a
Current Ratio1.01
Income Statement (mra) ($M)
Natural Gas Sales Revenue48,868,000.00
Natural Gas Liquids Sales Revenue44,103,000.00
Oil Sales Revenue336,931,000.00
Sales Revenue Net429,902,000.00
Operating Income105.28
Net Income83.56
Earnings Per Share Basic0.32
Earnings Per Share Diluted0.32
Cash Flow Statement (mra) ($M)
Cash From Operations259.92
Cash from Investing-992.31
Cash from Financing-992.31
Identifiers and Descriptors
CUSIP15136A102
Central Index Key (CIK)1658566
Related CUSIPS
15136A902 15136A110
Industry Groups

Split History

Stock splits are used by Centennial Resource Development, Inc. to keep share prices within reasonable numbers to encourage investment. If the share price of a security gets too high, a company can perform a stock split by issuing all shareholders an extra share, thereby halving the price of an individual share. If the share price gets too low, companies can do reverse splits. This is common when share prices drop below $1.00 and company's become in danger of being delisted. However, because of the cost, stock splits are not a normal business occurrence.

Coming soon

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...

Related News Stories

Centennial Resource Development's (CDEV) CEO Mark Papa on Q1 2018 Results - Earnings Call Transcript

2018-05-15 seekingalpha
Good morning, and welcome to Centennial Resource Development's Conference Call to discuss its First Quarter 2018 Earnings. Today's call is being recorded. A replay of the call will be accessible until May 23, 2018, by dialing 855-859-2056 and entering the conference ID number 1872225 or by visiting Centennial's website at www.cdevinc.com. (6-0)

U.S. Shale: NAV Analysis Of Anadarko Basin E&Ps

2018-05-10 seekingalpha
These reports value about 50 US shale exploration and production companies (“E&Ps”) based on their net asset values (“NAV”). Each quarter, I expect to publish new reports with updated quarterly information. Also, because I track a substantial amount of information on each company, from time to time I also intend to publish E&P sector wide trends reports. (230-3)

CEO: US Shale Producers Will Not Offset Iran Supply Drop Post-Deal Exit

2018-05-09 rigzone
HOUSTON, May 9 (Reuters) - U.S. shale producers will not boost output to offset any global oil squeeze after President Donald Trump abandoned the Iran nuclear deal, one of the industry's most prominent executives said on Wednesday. (26-0)

U.S. Shale: NAV Analysis Of Eagle Ford Shale E&Ps

2018-05-08 seekingalpha
These reports value about 50 US shale exploration and production companies ("E&Ps") based on their net asset values ("NAV"). Each quarter, I expect to publish new reports with updated quarterly information. Also, because I track a substantial amount of information on each company, from time to time I also intend to publish E&P sector wide trends reports. (180-2)

Oil Stock Q1 Earnings to Watch on May 8: XEC, OXY, FANG, CDEV

2018-05-07 zacks
With releases from 409 S&P 500 members, the Q1 earnings season is at its tail end. The companies recorded year-over-year earnings growth of 24% on 9.3% higher revenues. (55-0)

CUSIP: 15136A102